Please use this identifier to cite or link to this item: http://hdl.handle.net/10397/81784
PIRA download icon_1.1View/Download Full Text
DC FieldValueLanguage
dc.contributorDepartment of Health Technology and Informatics-
dc.creatorYu, TT-
dc.creatorLam, SK-
dc.creatorTo, LH-
dc.creatorTse, KY-
dc.creatorCheng, NY-
dc.creatorFan, YN-
dc.creatorLo, CL-
dc.creatorOr, KW-
dc.creatorChan, ML-
dc.creatorHui, KC-
dc.creatorChan, FC-
dc.creatorHui, WM-
dc.creatorNgai, LK-
dc.creatorLee, FKH-
dc.creatorAu, KH-
dc.creatorYip, CWY-
dc.creatorZhang, Y-
dc.creatorCai, J-
dc.date.accessioned2020-02-10T12:29:10Z-
dc.date.available2020-02-10T12:29:10Z-
dc.identifier.urihttp://hdl.handle.net/10397/81784-
dc.language.isoenen_US
dc.publisherFrontiers Research Foundationen_US
dc.rightsCopyright © 2019 Yu, Lam, To, Tse, Cheng, Fan, Lo, Or, Chan, Hui, Chan, Hui, Ngai, Lee, Au, Yip, Zhang and Cai. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (https://creativecommons.org/licenses/by/4.0/). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.en_US
dc.rightsThe following publication Yu T, Lam S, To L, Tse K, Cheng N, Fan Y, Lo C, Or K, Chan M, Hui K, Chan F, Hui W, Ngai L, Lee FK, Au K, Yip CW, Zhang Y and Cai J (2019) Pretreatment Prediction of Adaptive Radiation Therapy Eligibility Using MRI-Based Radiomics for Advanced Nasopharyngeal Carcinoma Patients. Front. Oncol. 9:1050, 1-10 is available at https://dx.doi.org/10.3389/fonc.2019.01050en_US
dc.subjectRadiomicsen_US
dc.subjectNasopharyngeal carcinomaen_US
dc.subjectAdaptive radiation therapyen_US
dc.subjectTumor shrinkageen_US
dc.subjectMagnetic resonance imagingen_US
dc.titlePretreatment prediction of adaptive radiation therapy eligibility using MRI-based radiomics for advanced nasopharyngeal carcinoma patientsen_US
dc.typeJournal/Magazine Articleen_US
dc.identifier.spage1-
dc.identifier.epage10-
dc.identifier.volume9-
dc.identifier.doi10.3389/fonc.2019.01050-
dcterms.abstractBackground and purpose: Adaptive radiotherapy (ART) can compensate for the dosimetric impacts induced by anatomic and geometric variations in patients with nasopharyngeal carcinoma (NPC); Yet, the need for ART can only be assessed during the radiation treatment and the implementation of ART is resource intensive. Therefore, we aimed to determine tumoral biomarkers using pre-treatment MR images for predicting ART eligibility in NPC patients prior to the start of treatment.-
dcterms.abstractMethods: Seventy patients with biopsy-proven NPC (Stage II-IVB) in 2015 were enrolled into this retrospective study. Pre-treatment contrast-enhanced T1-w (CET1-w), T2-w MR images were processed and filtered using Laplacian of Gaussian (LoG) filter before radiomic features extraction. A total of 479 radiomics features, including the first-order (n = 90), shape (n = 14), and texture features (n = 375), were initially extracted from Gross-Tumor-Volume of primary tumor (GTVnp) using CET1-w, T2-w MR images. Patients were randomly divided into a training set (n = 51) and testing set (n = 19). The least absolute shrinkage and selection operator (LASSO) logistic regression model was applied for radiomic model construction in training set to select the most predictive features to predict patients who were replanned and assessed in the testing set. A double cross-validation approach of 100 resampled iterations with 3-fold nested cross-validation was employed in LASSO during model construction. The predictive performance of each model was evaluated using the area under the receiver operator characteristic (ROC) curve (AUC).-
dcterms.abstractResults: In the present cohort, 13 of 70 patients (18.6%) underwent ART. Average AUCs in training and testing sets were 0.962 (95%CI: 0.961-0.963) and 0.852 (95%CI: 0.847-0.857) with 8 selected features for CET1-w model; 0.895 (95%CI: 0.893-0.896) and 0.750 (95%CI: 0.745-0.755) with 6 selected features for T2-w model; and 0.984 (95%CI: 0.983-0.984) and 0.930 (95%CI: 0.928-0.933) with 6 selected features for joint T1-T2 model, respectively. In general, the joint T1-T2 model outperformed either CET1-w or T2-w model alone.-
dcterms.abstractConclusions: Our study successfully showed promising capability of MRI-based radiomics features for pre-treatment identification of ART eligibility in NPC patients.-
dcterms.accessRightsopen accessen_US
dcterms.bibliographicCitationFrontiers in oncology, 16 Oct. 2019, v. 9, 1050, p. 1-10-
dcterms.isPartOfFrontiers in oncology-
dcterms.issued2019-
dc.identifier.isiWOS:000497841300001-
dc.identifier.scopus2-s2.0-85074517402-
dc.identifier.pmid31681588-
dc.identifier.eissn2234-943X-
dc.identifier.artn1050-
dc.description.validate202002 bcrc-
dc.description.oaVersion of Recorden_US
dc.identifier.FolderNumberOA_Scopus/WOSen_US
dc.description.pubStatusPublisheden_US
Appears in Collections:Journal/Magazine Article
Files in This Item:
File Description SizeFormat 
Yu_Pretreatment_Adaptive_Radiation.pdf1.97 MBAdobe PDFView/Open
Open Access Information
Status open access
File Version Version of Record
Access
View full-text via PolyU eLinks SFX Query
Show simple item record

Page views

142
Last Week
2
Last month
Citations as of Mar 24, 2024

Downloads

161
Citations as of Mar 24, 2024

SCOPUSTM   
Citations

43
Citations as of Mar 28, 2024

WEB OF SCIENCETM
Citations

38
Last Week
0
Last month
Citations as of Mar 28, 2024

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.